Japan news from FierceVaccines
News
Individual investors buy into vaccination bond issue
Japanese investors have snapped up a $223 million bond program to fund vaccination campaigns in developing countries. The idea is that the investors' money will be used to pay for the upfront costs Read more...
Japanese R&D team targets next gen flu jabs
Investigators in Japan have designed a new vaccine that has been effective in animal tests against multiple strains of influenza, including varieties of the dread bird flu. Using a peptide derived Read more...
Get more Japan coverage at:
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends